APA (7th ed.) Citation

S, N., Y, K., K, T., AI, H., Y, M., T, K., . . . S, T. (2024). Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: A multicenter prospective cohort study in the Setouchi Breast Project-14. Breast cancer research and treatment, 208(1), 67. https://doi.org/10.1007/s10549-024-07395-7

Chicago Style (17th ed.) Citation

S, Nakamoto, et al. "Baseline Gut Microbiota as a Predictive Marker for the Efficacy of Neoadjuvant Chemotherapy in Patients with Early Breast Cancer: A Multicenter Prospective Cohort Study in the Setouchi Breast Project-14." Breast Cancer Research and Treatment 208, no. 1 (2024): 67. https://doi.org/10.1007/s10549-024-07395-7.

MLA (9th ed.) Citation

S, Nakamoto, et al. "Baseline Gut Microbiota as a Predictive Marker for the Efficacy of Neoadjuvant Chemotherapy in Patients with Early Breast Cancer: A Multicenter Prospective Cohort Study in the Setouchi Breast Project-14." Breast Cancer Research and Treatment, vol. 208, no. 1, 2024, p. 67, https://doi.org/10.1007/s10549-024-07395-7.